by Maya Koleva | Aug 22, 2024 | Blog
Contrary to PR and marketing dogma, what draws consumers to no-and-low alcoholic (NOLO) drinks is not health and sobriety but rather taste and innovative flavour experiences. The research gap There has been widespread support for NOLO drinks, including by government...
by Maya Koleva | Mar 13, 2024 | Blog
Reading time: 3 min As US drug pricing negotiations are making headlines every day, our analysis found that pharma’s reputation is suffering mainly because of media misconceptions that companies can clear out. What we found: Our study of 1,705 English-language...
by Maya Koleva | Mar 13, 2024 | Blog
Reading time: 3 min While Wegovy reshaped public attitudes about obesity, its maker Novo Nordisk oversaw critical reputational threats, highlighting that product success alone cannot safeguard pharma companies without a comprehensive, data-driven reputation management...
